Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion.

The effect of low-dose (15 ml/kg) intracoronary perfluorochemical (Fluosol-DA) on infarct size, regional myocardial blood flow, and ventricular function was studied in 20 anesthetized closed-chest dogs subjected to 11/2 hr of proximal left anterior descending occlusion. In this preparation reperfusion was simulated with fibrinolytic therapy. The animals were randomly assigned one of two treatment groups and given 15 ml/kg of either oxygenated intracoronary perfluorochemical (n = 9) or saline (n = 11). Contrast ventriculograms were obtained at baseline, 1 hr after occlusion, and at 24 hr after reperfusion and were analyzed with a radial fractional shortening method. Regional myocardial blood flow was measured with radioactive microspheres. At 24 hr the area at risk was defined in vivo with monastryl blue staining and the area of necrosis was estimated after incubation of left ventricular slices with triphenyltetrazolium chloride. No significant changes were noted in heart rate, blood pressure, pulmonary capillary wedge pressure, or dP/dt during the experimental protocol. Infarct size was significantly reduced (p less than .02) in the perfluorochemical-treated group, both when expressed as a percentage of the total left ventricular mass (7.9 +/- 1.7% vs 14.7 +/- 2.5%) and as a percentage of the area at risk (20.1 +/- 5.0% vs 46.8 +/- 8.5%). This was associated with significant improvement in fractional shortening in the jeopardized zone at 24 hr after reperfusion. Although endocardial blood flow was significantly greater in the central ischemic zone and lateral region at risk immediately after reperfusion in the perfluorochemical-treated group, no difference was found 1 hr after reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  A. K. Dawson,et al.  Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

[2]  R. Rude,et al.  Effects of fluorocarbons with and without oxygen supplementation on cardiac hemodynamics and energetics. , 1984, The American journal of cardiology.

[3]  H. Otani,et al.  In Vitro Study on Contribution of Oxidative Metabolism of Isolated Rabbit Heart Mitochondria to Myocardial Reperfusion Injury , 1984, Circulation research.

[4]  L. Fink,et al.  Effect of perfluorochemical blood substitutes on human neutrophil function , 1984, Transfusion.

[5]  B. Lucchesi,et al.  Canine Myocardial Reperfusion Injury: Its Reduction by the Combined Administration of Superoxide Dismutase and Catalase , 1984, Circulation research.

[6]  V. Gott,et al.  Oxygenated perfluorocarbon cardioplegia prevents oxygen free-radical reperfusion injury , 1984 .

[7]  L. Fink,et al.  Effects of perfluorochemical on phagocytic function of leukocytes , 1983, Transfusion.

[8]  E. Braunwald,et al.  Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. , 1983, Circulation.

[9]  L. Becker,et al.  Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarction. , 1983, Journal of the American College of Cardiology.

[10]  S. Paulin,et al.  Computerized image analysis for quantitative measurement of vessel diameter from cineangiograms. , 1983, Circulation.

[11]  S. Vatner,et al.  Salvage of Myocardial Function by Coronary Artery Reperfusion 1, 2, and 3 Hours after Occlusion in Conscious Dogs , 1983, Circulation research.

[12]  J. T. Shepherd,et al.  Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. , 1983, Science.

[13]  L. Cohn,et al.  Effect of fluocarbon exchange transfusion on myocardial infarction size in dogs. , 1983, The American journal of cardiology.

[14]  J. Greenfield,et al.  Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction. , 1983, The Journal of clinical investigation.

[15]  P. R. Frederick,et al.  A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. , 1983, The New England journal of medicine.

[16]  D. Berman,et al.  Nonsurgical reperfusion in evolving myocardial infarction. , 1983, Journal of the American College of Cardiology.

[17]  D. Beanlands,et al.  The Time Course and Characterization of Myocardial Hemorrhage After Coronary Reperfusion in the Anesthetized Dog , 1983, Circulation.

[18]  E. E. van der Wall,et al.  Effects of Spontaneous and Streptokinase‐induced Recanalization on Left Ventricular Function After Myocardial Infarction , 1983, Circulation.

[19]  G. Schmid-Schönbein,et al.  Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. , 1983, The American journal of pathology.

[20]  K. Karsch,et al.  Thrombolysis in acute experimental myocardial infarction. , 1983, Journal of the American College of Cardiology.

[21]  E. Braunwald,et al.  The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.

[22]  J. McCord,et al.  The pathophysiology of superoxide: roles in inflammation and ischemia. , 1982, Canadian journal of physiology and pharmacology.

[23]  P. Vanhoutte,et al.  Heterogeneous Behavior of the Canine Arterial and Venous Wall: Importance of the Endothelium , 1982, Circulation research.

[24]  V. Gott,et al.  Optimal myocardial protection with fluosol cardioplegia. , 1982, The Annals of thoracic surgery.

[25]  D. Camarillo,et al.  The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. , 1982, The New England journal of medicine.

[26]  R. Geyer Oxygen transport in vivo by means of perfluorochemical preparations. , 1982, The New England journal of medicine.

[27]  M. Claeys,et al.  Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. , 1982, The Journal of pharmacology and experimental therapeutics.

[28]  E. Braunwald,et al.  Effects of intravenous fluorocarbons during and without oxygen enhancement on acute myocardial ischemic injury assessed by measurement of intramyocardial gas tensions. , 1982, American heart journal.

[29]  K. Karsch,et al.  Effects of nonsurgical coronary reperfusion on the left ventricle in human subjects compared with conventional treatment. Study of 18 patients with acute myocardial infarction treated with intracoronary infusion of streptokinase. , 1982, The American journal of cardiology.

[30]  H. Ohyanagi,et al.  Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases. , 1982, Annals of surgery.

[31]  E. Braunwald,et al.  Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction. , 1981, The New England journal of medicine.

[32]  V. Gott,et al.  Superiority of Perfluorocarbon Cardioplegia Over Blood or Crystalloid Cardioplegia , 1981, Circulation.

[33]  M. Fishbein,et al.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.

[34]  E. Braunwald,et al.  Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. , 1981, Science.

[35]  S. Wickline,et al.  Platelet trapping in myocardial infarct in baboons: therapeutic effect of aspirin. , 1980, The American journal of cardiology.

[36]  H. Vik-mo Platelet accumulation in the myocardium during acute nonthrombotic coronary artery occlusion in dogs. , 2009, Scandinavian journal of haematology.

[37]  J. Dingle,et al.  Sequential lysosomal alterations during cardiac ischemia. I. Biochemical and immunohistochemical changes. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[38]  S. Epstein,et al.  Contractile damage from reperfusion after transient ischemia in the dog. , 1978, The Journal of thoracic and cardiovascular surgery.

[39]  G. Hutchins,et al.  Myocardial Consequences of Coronary Artery Bypass Graft Surgery: The Paradox of Necrosis in Areas of Revascularization , 1977, Circulation.

[40]  J. Lowe,et al.  The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.

[41]  J. Mustard,et al.  Clinical pharmacology of platelets. , 1977, Blood.

[42]  G. Buckberg Left ventricular subendocardial necrosis. , 1977, The Annals of thoracic surgery.

[43]  F. Baumann,et al.  Myocardial reperfusion, a cause of ischemic injury during cardiopulmonary bypass. , 1976, Surgery.

[44]  C. Costantini,et al.  Revascularization after 3 hours of coronary arterial occlusion: effects on regional cardiac metabolic function and infarct size. , 1975, The American journal of cardiology.

[45]  V. Mathur,et al.  Maximal revascularization (reperfusion) in intact conscious dogs after 2 to 5 hours of coronary occlusion. , 1975, The American journal of cardiology.

[46]  R. Kloner,et al.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.

[47]  D A Whalen,et al.  Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. , 1974, The American journal of pathology.

[48]  J. Ross,et al.  Deleterious effects due to hemorrhage after myocardial reperfusion. , 1974, The American journal of cardiology.

[49]  B E Sobel,et al.  Coronary Artery Reperfusion: II. REDUCTION OF MYOCARDIAL INFARCT SIZE AT 1 WEEK AFTER THE CORONARY OCCLUSION , 1972 .

[50]  F. Gollan,et al.  Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric Pressure , 1966, Science.